Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash Equivalents | 1,839.43 | 1,362.70 | 66.00 | 187.00 |
Cashand Short Term Investments | 1,839.43 | 3,762.83 | 3,242.72 | 3,005.75 |
Accounts Receivable- Trade Net | 1,810.62 | 1,024.17 | 1,256.32 | 713.18 |
Total Receivables Net | 1,810.62 | 1,035.97 | 1,292.75 | 747.88 |
Total Inventory | 1,655.24 | 1,978.19 | 1,229.19 | 1,288.17 |
Other Current Assets Total | 339.86 | 110.00 | 73.26 | 70.93 |
Total Current Assets | 5,645.15 | 6,900.81 | 5,852.08 | 5,123.64 |
Property/ Plant/ Equipment Total- Net | 3,830.15 | 1,736.10 | 1,680.40 | 1,292.04 |
Goodwill Net | 242.26 | - | - | - |
Intangibles Net | 112.22 | 11.66 | 12.54 | - |
Long Term Investments | 655.91 | 0.00 | - | - |
Note Receivable- Long Term | 27.49 | 22.52 | 7.20 | 4.50 |
Other Long Term Assets Total | 148.06 | 106.44 | 281.41 | 75.90 |
Total Assets | 10,661.25 | 8,777.54 | 7,833.62 | 6,496.08 |
Accounts Payable | 862.69 | 587.35 | 462.85 | 400.73 |
Current Portof LT Debt/ Capital Leases | 230.95 | 0.71 | 0.26 | 0.30 |
Other Currentliabilities Total | 304.72 | 141.07 | 118.91 | 111.51 |
Total Current Liabilities | 1,398.36 | 729.13 | 582.03 | 512.53 |
Long Term Debt | 106.54 | 3.26 | 3.82 | 3.93 |
Capital Lease Obligations | 34.68 | 0.48 | 0.66 | 0.76 |
Total Long Term Debt | 141.22 | 3.74 | 4.48 | 4.70 |
Total Debt | 372.17 | 4.45 | 4.74 | 5.00 |
Deferred Income Tax | 220.12 | 84.20 | 87.76 | 73.88 |
Other Liabilities Total | 177.70 | 1.73 | 1.73 | 1.73 |
Total Liabilities | 1,937.40 | 818.81 | 676.00 | 592.84 |
Common Stock Total | 16.47 | 16.47 | 16.43 | 16.36 |
Retained Earnings( Accumulated Deficit) | 8,707.37 | 6,023.52 | 5,253.97 | 4,054.57 |
Total Equity | 8,723.84 | 7,958.72 | 7,157.62 | 5,903.24 |
Total Liabilities Shareholders' Equity | 10,661.25 | 8,777.54 | 7,833.62 | 6,496.08 |
Total Common Shares Outstanding | 16.47 | 16.47 | 16.43 | 16.36 |
Tangible Book Valueper Share Common Eq | 508.13 | 482.51 | 434.87 | 360.85 |
Cash | - | 546.20 | 249.82 | 305.47 |
Short Term Investments | - | 1,853.94 | 2,926.89 | 2,513.29 |
Prepaid Expenses | - | 13.82 | 14.16 | 10.91 |
Property/ Plant/ Equipment Total- Gross | - | 2,459.19 | 2,259.09 | 1,768.50 |
Accumulated Depreciation Total | - | -723.09 | -578.68 | -476.47 |
Notes Payable/ Short Term Debt | - | 0.00 | 0.00 | 0.00 |
Additional Paid- In Capital | - | 1,928.42 | 1,895.47 | 1,840.11 |
Other Equity Total | - | -9.69 | -8.25 | -7.79 |
Gland Pharma Dividend Gland Pharma Bonus Gland Pharma News Gland Pharma AGM Gland Pharma Rights Gland Pharma Splits Gland Pharma Board Meetings Gland Pharma Key Metrics Gland Pharma Shareholdings Gland Pharma Profit Loss Gland Pharma Cashflow Gland Pharma Q1 Results Gland Pharma Q2 Results Gland Pharma Q3 Results Gland Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks